Protective Properties of Inactivated Virosomal Influenza Vaccine

Autor: М.К. Erofeeva, S.J. Melnikhov, Korovkin Sa, E.M. Voicehovskaya, Marina Stukova, I.J. Nickonorov, V.L. Maksakova, E.A. Okhapkina, O.S. Konshina, Oleg I. Kiselev

Publikováno v: Procedia in Vaccinology. 8:24-33

Currently, application of new technological solutions for the implementation of strategies for improving influenza vaccines are up to date and modern. In this study, we present data obtained in the evaluation of the safety and immunogenicity of the n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85827050505662a591a06c3b0a0772ad

[Antimicrobial activity of dioxidine and a dioxidin-containing preparation «Nosolin-Ultra, nasal drops».]

Autor: Detysheva EV; State Research Center for Applied Microbiology and Biotechnology, Obolensk, Moscow region, Russia., Fursova NK; State Research Center for Applied Microbiology and Biotechnology, Obolensk, Moscow region, Russia., Korovkin SA; CJSC «FIRN-M», Obolensk, Moscow region, Russia.

Publikováno v: Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2020; Vol. 65 (4), pp. 244-250.

[Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2)].

Autor: Mazurkova NA, Ryndiuk NN, Shishkina LN, Ternovoĭ VA, Tumanov IuV, Bulychev LE, Skarnovich MO, Kabanov AS, Panchenko SG, Aleĭnikov RP, Il'ina TN, Kuzubov VI, Mel'nikov SIa, Mironov AN, Korovkin SA, Sergeev AN, Drozdov IG

Publikováno v: Vestnik Rossiiskoi akademii meditsinskikh nauk [Vestn Ross Akad Med Nauk] 2010 (3), pp. 15-20.

[Clinical trial of new inactivated influenza vaccine "Grifor"].

Autor: Zverev VV, Kiselev OI, Korovkin SA, Mironov AN, Mel'nikov SIa, Mikhaĭlova NA, Kostinov MP, Erofeeva MK, Solomina AA, Dyldina NV, Zhirova SN, Stukova MA

Publikováno v: Zhurnal mikrobiologii, epidemiologii i immunobiologii [Zh Mikrobiol Epidemiol Immunobiol] 2009 Mar-Apr (2), pp. 35-40.

[Development and preclinical study of new generation virosomal split influenza vaccine "Grifor"].

Autor: Mel'nikov SIa, Zverev VV, Korovkin SA, Mironov AN, Dyldina NV, Mikhaĭlova NA, Faĭzuloev EB, Lotte VD

Publikováno v: Zhurnal mikrobiologii, epidemiologii i immunobiologii [Zh Mikrobiol Epidemiol Immunobiol] 2009 Jan-Feb (1), pp. 21-6.